key: cord-0987513-j47fuuqs
authors: Solomon, Isaac H.; Padera, Robert F.
title: Answer to August 2020 Photo Quiz
date: 2020-07-23
journal: J Clin Microbiol
DOI: 10.1128/jcm.01108-20
sha: b10f9bce2596f11c96f42a88db7fc94390f89a7d
doc_id: 987513
cord_uid: j47fuuqs

nan

complicating the histological differential. Thrombi are generally not subtle and can be recognized microscopically by pale eosinophilic material occluding a blood vessel lumen. Coagulopathy in COVID-19 is associated with increased risk of death, with laboratory testing revealing increased levels of D-dimer, lactate dehydrogenase, and ferritin (6) . Whether increased rates of pulmonary embolism are due to specific effects of the virus has yet to be resolved (7) .

US CDC real-time reverse transcription PCR panel for detection of severe acute respiratory syndrome coronavirus 2

Pathology and pathogenesis of SARS-CoV-2 associated with fatal coronavirus disease, United States

Report from the American Society for Microbiology COVID-19 International Summit

SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor

Post-mortem examination of COVID19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs suggesting vascular dysfunction

Coagulation abnormalities and thrombosis in patients with COVID-19

Pulmonary arterial thrombosis in COVID-19 with fatal outcome: results from a prospective, single-center, clinicopathologic case series